Stock image Xigduo
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.24MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024: Xigduo Box Of Medication With Dapagliflozin Active Substance By AstraZeneca, Used For Treatment Of Type 2 Diabetes
Image, 2.41MB, 3024 × 4032 jpg
Prague,Czech Republic-August 7 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA,used For Treatment Of Type 2 Diabetes.
Image, 2.2MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.47MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.54MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.37MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.27MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.31MB, 3024 × 4032 jpg
Prague,Czech Republic-August 7 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA,used For Treatment Of Type 2 Diabetes.
Image, 2.27MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.49MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.53MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.25MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.2MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.31MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA,used For Treatment Of Type 2 Diabetes.
Image, 2.18MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.47MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.52MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.26MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.37MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.51MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.34MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.33MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.48MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.5MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.38MB, 3024 × 4032 jpg
Prague,Czech Republic-August 7 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA,used For Treatment Of Type 2 Diabetes.
Image, 2.21MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.14MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.24MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA,used For Treatment Of Type 2 Diabetes.
Image, 2.08MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.49MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.21MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: XIGDUO Box Of Medication With DAPAGLIFLOZIN And METFORMIN Active Substances By ASTRAZENECA,used For Treatment Of Type 2 Diabetes.
Image, 2.25MB, 4032 × 3024 jpg
Page 1 >> Next